Wave Life Sciences .(WVE) - 2025 Q2 - Quarterly Results

Exhibit 99.1 Wave Life Sciences Reports Second Quarter 2025 Financial Results and Provides Business Update Cash and cash equivalents of $208.5 million as of June 30, 2025, with runway expected into 2027 Investor conference call and webcast at 8:30 a.m. ET today CAMBRIDGE, Mass., July 30, 2025 – Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, today announced financial results for the second quar ...